Research & Development

天天啪在线视频青青草av在线av俞敏洪:家族成员一起创业的利与弊

發布時間︰

  “夫君!”甦稚揚起上身喊住雲瑯。   雲瑯回憶了一下,大河在上游尤其是隴中一帶很少有改道的記錄,遂點點頭道︰“有六成的可行性,不過,還是需要趙破奴帶人親自去試驗一下。”天天啪在线视频   微臣卻覺得霍去病沒有那麼瘋,一定有什麼我不知道的事情要發生了。青青草av   “老虎這時候之所以這麼黏我們,是因為它馬上就要去驪山里去找母老虎了。”   周鴻勒住戰馬大笑道︰“你們坐在台子上做什麼,麥子才長出來,沒人偷!”在线av   雖然不起眼,卻讓人舒服的厲害。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.


Connect? Registries


The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo